Hims & Hers Health Inc Ordinary Shares - Class A (HIMS)
Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA and an Investment Account
Sell
$19.15
Buy
$19.24
$-0.70 (-3.53%)
Prices updated at 03 Apr 2026, 00:59 EDT
| Prices minimum 15 mins delay
Prices in USD
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Income statement
Year | 2024 | 2025 |
|---|---|---|
| 1,477m | 2,348m | |
| 1,173m | 1,733m | |
| 62m | 106m | |
| 4.19 | 4.50 | |
| 126m | 128m | |
| 79m | 160m | |
| Sales, General and administrative | 847m | 1,192m |
| Interest expenses | - | - |
| Provision for income taxes | -54m | -4m |
| Operating expenses | 1,111m | 1,628m |
| Income before taxes | 72m | 124m |
| Net income available to common shareholders | 126m | 128m |
| 0.58 | 0.57 | |
| Net interest income | - | - |
| Advertising and promotion | - | - |
| Net investment income, net | - | - |
| Realised capital gains (losses), net | - | - |
| Total benefits, claims and expenses | - | - |
| Earnings per share (diluted) | 0.53 | 0.51 |
| Free cash flow per share | 0.6569 | 0.4711 |
| Book value/share | 1.9926 | 2.5566 |
| Debt equity ratio | 0.019836 | 2.062653 |
Balance sheet
Year | 2024 | 2025 |
|---|---|---|
| Current assets | 396m | 768m |
| Current liabilities | 221m | 404m |
| Total capital | 477m | 1,514m |
| Total debt | 11m | 1,121m |
| Total equity | 477m | 541m |
| Total non current liabilities | - | - |
| Loans | - | 973m |
| Total assets | 708m | 2,155m |
| Total liabilities | - | - |
| Cash and cash equivalents | 221m | 229m |
| Common stock | 221m | 227m |
Cash flow
Year | 2024 | 2025 |
|---|---|---|
| Cash at beginning of period | 98m | 221m |
| Cash dividends paid | - | - |
| 198m | 57m | |
| Investments (gains) losses | -19m | -1,025m |
| 221m | 229m | |
| Net income | - | - |
| 251m | 300m | |
| -53m | -243m |
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.